The Royal Pharmaceutical Society (RPS) has appointed Neville Carter as its new chief education and membership officer.
Neville joins RPS from the Royal Society of Medicine (RSM) where he is currently director of engagement, leading a team of over 60 and responsible for creating a
combined directorate accountable for education, membership, philanthropy, and business development.
He has, in particular, led on the development of a digital education strategy and launched professional development training programmes for members.
Prior to joining the RSM, Neville worked as director of product and sales at the British Medical Association with responsibility for membership growth, supporting
corporate transformation and developing and managing member benefits and relationships with third-party providers to support revenue growth. He also has senior
manager experience at the RAC and at British Airways.
Commenting on the appointment, Paul Bennett, RPS CEO, said: "I'm delighted that Neville will be joining our Executive team. He brings a wealth of relevant experience
and this, in combination with a strong existing education and membership team at RPS and a clear ambition to strengthen the relevant functions further, will enable
the organisation to deliver a dynamic offering for our members.
The Pharmacists' Defence Association (PDA) said it has supported the application of the Royal Pharmaceutical Society (RPS) to rejoin the International
Pharmaceutical Federation (FIP), the global body representing the interests of pharmacy.
Under FIP rules, if a new application from an additional organisation from the same country applies to join, the existing members in that country are consulted
about that decision and are asked for their approval before FIP council members determine if the application is accepted.
The PDA joined FIP earlier this year, and RPS, which has decided not to renew FIP membership at the end of last year, has now submitted a fresh application to join.
RPS decision to leave, taken after a vote, has invited much criticism. The organisation, a founding member, had attributed high membership fees and associated costs
for leaving FIP
While the PDA has confirmed that it would not oppose the membership application of the RPS, it has asked FIP to find a suitable method to ascertain a transparent
declaration of membership numbers from the RPS in the event of FIP Council deciding to admit RPS.
The Association of the British Pharmaceutical Industry (ABPI) has suspended the membership of Novo Nordisk for two years due to serious breaches of its Code
of Practice.
The action was taken by the ABPI Board following an investigation and appeals process conducted by the Prescription Medicines Code of Practice Authority (PMCPA)
which found Novo Nordisk to be in breach of the ABPI Code of Practice, including Clause 2 which deals with actions "likely to bring discredit on, or reduce
confidence in, the pharmaceutical industry".
Having considered the case and requesting a further detailed audit of Novo Nordisk's compliance processes, the ABPI Board decided to suspend Novo Nordisk from ABPI
membership.
Susan Rienow, President-Elect, ABPI, said: "The ABPI Board has carefully considered the PMCPA's case report into Novo Nordisk and the subsequent audit of their
compliance procedures.
"The Board expressed significant concern about Novo Nordisk's compliance activities and the very serious issues identified. As a result, the ABPI Board have taken
the decision to suspend Novo Nordisk from ABPI membership.
The National Pharmacy Association (NPA) has announced the retirement of its Chief Executive, Mark Lyonette.
Mark will retire in 2024. The association has announced his retirement well in advance so that the Board can start work with a leading recruitment agency to search
for the new Chief Executive.
"The Board is keen to build on the strong foundations established and ensure there is a seamless transition and minimum disruption to the business once the new Chief
Executive is in post," said the association.
Mark said: "After five years at the NPA and 40 years working for and leading national membership organisations, I am looking forward to living a different life.
"I am pleased that in the time that I have been with the NPA we have grown both the membership and customer base and created a profitable, stable membership
organisation.
"Alongside our NPA Insurance company, the association is well set to help members face the future.
"Meanwhile there is much to do to ensure that 2023 is another good year in terms of the NPA delivering consistently for members. The process of changing Chief
Executive won't deflect us from our vital work."
The Pharmacists' Defence Association (PDA) has become a member of the International Pharmaceutical Federation (FIP).
On Thursday (22 September), the FIP council voted to welcome the PDA as a full member of the global federation of organisations that brings together and advances
pharmacy.
Mark Koziol, PDA chairman, said: "Being admitted to FIP with such a decisive level of support from its Council means that the PDA can ensure that UK pharmacists
can enjoy a clear and powerful voice representing their collective professional interests at global level, which of late they could not.
"Bringing one of the largest pharmacy membership organisations in the world to FIP also gives the PDA significant influence in being able to inform the policies of
the World Health Organisation. This means that the PDA can do even more for members by helping to make pharmacy practice more professionally fulfilling for them."
"The PDA constantly seeks ways to provide even better support for members; membership of FIP will give the PDA much more influence and will result in better outcomes
for pharmacists," the association said.
To support humanitarian crises in other parts of the world, the PDA approached FIP, as a global pharmacy leadership organisation.
The Pharmacists' Defence Association (PDA) has urged its member - employed pharmacists and locum pharmacists to share their view on UK Commission on Pharmacy
Professional Leadership report.
The four government Chief Pharmacists have published their commission's proposal for how pharmacy leadership may develop in the UK.
The association 'strongly' believes that just as it was the members of the profession that established their previous pharmacist professional leadership bodies, so
it is for pharmacists to determine if they agree with these proposals and to decide what arrangements they want in future.
"As an organisation that has exclusively in its membership the employed and locum pharmacists in the UK, the PDA wants to ensure that it can reflect the views of
frontline pharmacists in any future discussions and decisions that could impact upon their careers.
Pharmacists are encouraged to read the report, to consider its content and then ensure they respond to the forthcoming communication from the PDA."
The commission report says that existing leadership bodies have "relatively low levels of membership" but does not provide details. It has also stated that it has
received submissions to its consultation from many pharmacy organisations.
The Association of Independent Multiple Pharmacies (AIMp) has changed its name to the Independent Pharmacies Association (IPA).
AIMp, now IPA, stated that rebranding was prompted by the demand from independent community pharmacists for an association that properly represents their interests.
The membership of the Independent Pharmacies Association will not be restricted to pharmacy owners with multiple branches, as was the case with AIMp, but will
be open to all independents, it announced today (Tuesday).
It believes that the switch will "provide a clearer identity and afford a strong voice to the thousands of independent pharmacies in England and Wales."
Furthermore, the IPA noted that it will not primarily function as an insurance organisation with membership attached, but it will be "fighting for and
representing its members across all fronts."
To provide a portable access of Pharmacy Support and Advice Service to pharmacists and technicians, the National Pharmacy Association (NPA) has launched an 'Associate Pharmacist' subscription.
The service, comprising priority news-feed and email alerts, also includes NPA Learn - the association's Learning and Development hub.
The offering to associates includes an annual online flu refresher or discounted full face-to-face vaccination training programme.
NPA director of membership, Simon Tebbutt, said: "Associate Pharmacist is an offer to individuals, not to pharmacy businesses. We find that many pharmacists and technicians come into contact with NPA resources and like them, experiencing their quality as they move from pharmacy to pharmacy, either as a locum or as part of their career-building.
The Royal Pharmaceutical Society (RPS) has re-joined the International Pharmaceutical Federation (FIP) after reflecting its commitment to international
collaboration and the advancement of the pharmacy profession.
RPS President Professor Claire Anderson said: "Members told us they wanted to see us re-join FIP to further our commitment to international partnerships which
support education and advocacy to develop and progress the pharmacy profession.".
"We fully recognise the importance of international collaboration and the sharing of knowledge and best practice with our peers across the world.
"FIP are refocusing their membership offer and we're delighted to work with them on opportunities for professional development and increased visibility and
recognition for the pharmacy profession."
Paul Bennett, RPS CEO said: "Now that we have re-joined, our teams across RPS look forward to reinvigorating the close collaboration we have previously enjoyed
with our colleagues both within FIP itself, and across the breadth of FIP Member organisations to further our vision and mission".
With the UK government mandating a gender pay gap reporting by corporates and there is a lot of push for ethnicity pay gap report, there is a need for a similar push for having disability pay gap records, said Jay Muthu, director of Organization and People Capability at Entain Group.
"I think we need to kind of lobby the government to make that happen, but unfortunately a lot of disability organisations are still fighting for the basic rights,"
Muthu said during a panel discussion on Disability Inclusion In The Workplace held during the Pharmacy Business Diversity Conference on Thursday (December 9).
The session, moderated by the conference chair and BBC presenter Clive Myrie, also had Kate Nash OBE, founder and chief executive officer of Purple Space, which is the world's only professional development membership hub for disability employee resource groups.
Muthu said: "The challenges are from both sides. There is obviously the societal stigma (attached with disability). There are corporations not being aware and not
wanting to educate themselves, and then there is the government not really implementing the right kind of mechanisms to make it happen.
Has the government in England learned nothing from the Covid-19 pandemic? Nigel Swift, Managing Director of Rowlands Pharmacy, part of Numark, the UK's
largest pharmacy membership association, asks reflecting on the disorderly launch of this year's flu and Covid booster vaccination program as evidence to the
contrary.
"Community pharmacies play a crucial role in ensuring eligible individuals can easily access their free NHS flu and Covid vaccinations," Swift said, adding that
delivering this essential service necessitates pharmacy staff allocating time for preparation and appointment scheduling.
"Just a few weeks ago, NHSE informed us that the vaccination program would be postponed until October, prompting pharmacies to plan accordingly and notify
patients," he said. "However, NHSE has now reversed its decision and set the program to commence on Sept. 11. Pharmacy recommended an earlier start, but NHSE opted
for a delay instead, resulting in avoidable problems."
On Aug. 30, NHSE announced plans to move up the start of the autumn vaccination drive in England to September 11, deviating from the initial October schedule,
citing concerns about a new Covid-19 variant.
Online retail giant Amazon said on Tuesday (January 24) it is offering a $5 monthly subscription plan for U.S. Prime members that will cover a range of generic
drugs and their doorstep delivery, furthering the ecommerce giant's push into healthcare.
The program, named RxPass, includes more than 50 medications addressing over 80 chronic conditions such as high blood pressure, anxiety, diabetes and male pattern
baldness, Vin Gupta, Amazon Pharmacy's chief medical officer, has said.
However, customers enrolled in Medicare, Medicaid or any other government healthcare program will not be able to enrol in Amazon Pharmacy's RxPass service.
The average Prime member would save about $100 per year with RxPass, John Love, vice president of Amazon Pharmacy, said. Amazon Prime members in most U.S. states
can sign up for the program from January 24.
The flat $5 charge would be without insurance and on top of the Prime membership fee, which costs $139 per year in the United States.
The National Pharmacy Association (NPA) has announced that the Chief Pharmaceutical Officer for England, David Webb will be among the keynote speakers at the
Pharmacy Odyssey Conference on 13 October.
He and other special guests will discuss the future of community pharmacy within the NHS, during a day of insight and practical advice for pharmacy teams.
The NPA promises expert opinion on the current pressures in the sector and a thorough exploration of the long-term picture.
NPA Director of Membership, Simon Tebbutt, explains: "With the NPA centenary in 2021 behind us, this will be a foray into the future - mapping the coming decade,
and next half-century - as well as covering the many challenges of the present time."
The theme of the conference, to be held online and sponsored by Novo Nordisk, is Pharmacy Odyssey: Services, Supply and Sustainability.
Two more independent community pharmacists have been appointed to the UK Commission on Pharmacy Professional Leadership.
NPA board member Reena Barai and Sheelin McKeagney from Lurgan in Northern Ireland will join 25 other commission members, including Ash Soni who was the only
practising community pharmacist on the initial list published in June.
Welcoming the announcement, the National Pharmacy Association chief executive, Mark Lyonette, said: "To their great credit, the co-chairs of the commission and the
UK's chief pharmaceutical officers have listened to our request for more community pharmacy presence on the commission. They have acted swiftly to achieve a better
balance in its membership and we thank them for responding to our representations.
"Around 70 per cent of pharmacists practice in the community. With more voices from community pharmacy within the leadership commission, there is a greater sense
that the profession as a whole will be able to own the final recommendations when they are ultimately made."
ECG has launched a new 'simple and straightforward' Patient Group Direction (PGD) service for pharmacists working in primary care, together with a service
which offers direct access to an NHS Consultant for medical advice to offer robust safeguarding as and when needed.
Taking on more clinical services with the PGDs can feel daunting and a big responsibility for healthcare professionals. ECG's new medical advice service (for anyone
purchasing their PGDs) will offer pharmacists the opportunity to call and speak to a clinical member of the ECG team who will triage the calls and support them.
If required, the call will be connected to an experienced NHS Consultant to offer immediate medical advice. The service will start with a Monday-Friday 08:30-16:30hrs
provision with an option to increase to 24 /7 for those working out of hours. This is inclusive in the PGD pricing offer.
ECG has been the market leader in providing vaccination training to pharmacists since 2004, providing robust knowledge and clinical skills to enable pharmacists to
develop their private and NHS commissioned vaccination services (such as flu and covid). By developing their close working relationship with all of the multiples,
many smaller chains, membership groups and independents over the years, ECG has continued to further consolidate their 'one stop shop' approach to supporting the
sector.
ECG wants to offer this sector choices in the level of guidance and support that the individual healthcare professionals feel they need to offer safe care to
patients.
The Pharmacists' Defence Association (PDA) has undertaken an additional survey of pharmacists employed in the NHS, before deciding to hold their first-ever
ballot for industrial action.
The PDA has more than 7,000 NHS-employed pharmacists in membership and the union is actively considering balloting those members regarding strike action.
The association said: "The experience of some other unions has shown that the government's restrictive rules, designed to make it difficult for working people to
lawfully take industrial action, means trade unions should test members' strength of feeling before balloting."
"Trade unions are not only forced to rely upon postal ballots, but for lawful industrial action to be taken, the result must also meet three tests- at least 50% of
eligible voters must vote; at least 40% of eligible voters must vote 'yes' and a majority of votes must be for 'yes'."
The association is asking members in England, Northern Ireland and, Wales to show if their collective wish, insignificant enough strength, is for strike action. PDA
has emailed the survey to all its members in the NHS in the three nations and will close on Tuesday 3 January.
PHOENIX UK has appointed Harry McQuillan, former CEO of Community Pharmacy Scotland, as Chairman of Numark, a community pharmacy membership organisation.
It has over 3750 members ranging from single store pharmacies to large chains, spread across the 'Four Nations'. The organisation provides its members with the
professional and commercial support they need to deliver exceptional care to local communities.
As Numark Chairman, McQuillan will be front and central of representing the interests of the members, and will help ensure policy makers across the UK understand
fully "the potential of community pharmacy."
Steve Anderson, Group Managing Director, PHOENIX UK, commented: "Harry brings to our Numark partnership an outstanding wealth of experience and understanding of
how community pharmacy can work successfully with government officials and politicians.
The Royal Pharmaceutical Society (RPS), professional membership body for pharmacists and pharmacy, has published its manifesto for the general election,
highlighting key issues facing the next government after the election on July 4.
Local candidates are urged to recognise and support the vital role pharmacists play in supporting people's health.
The RPS teams are gearing up to influence government policy in various crucial areas. Their key asks include:
Ensuring Secure Patient Access to Medicines
Supporting a Better-Connected NHS
Enhancing Accessible Prescribing in Local Communities
Maximizing Health Improvement through Locally Accessible Pharmacy Teams
Supporting the Workforce to Deliver Patient Care
Unlocking the Potential of New Advances in Medicines
Supporting the UK's Global Position in Science and Research
Acknowledging the efforts of pharmacists and their teams, Professor Claire Anderson, President of the RPS, noted that they are "working incredibly hard to
maintain patient access to care amid workforce challenges, medicines shortages and financial pressures."
A pushup is a natural and effective way of building muscle and stamina. It is a no-cost workout, Where you don't need gym memberships. Want to know the benefits of all 25 types of pushups. Click on the link.
The International Pharmaceutical Federation (FIP) has offered a new resource to help countries self-assess readiness of their regulations to enable
pharmacist-delivered vaccination services and, where needed, to implement such regulations.
Developed by FIP's Regulators Advisory Group, it covers broad pharmacist-led roles related to vaccination from supply chain management to administration and
prescribing.
"This new resource from FIP is based on the experiences of professional regulators in countries where pharmacy-led vaccination has been successfully introduced
and regulated. With it, we aim to support regulators, policymakers and national organisations in developing strategies or enabling regulatory frameworks in
countries where the pharmacy workforce has a limited role in vaccination strategies so that it can contribute further to the global imperative of improving
immunisation coverage," said Brett Simmonds, group chair.
The "Pharmacy-led vaccination services: Regulatory self-assessment and implementation tool" aims to help identify strengths and areas for improvement in order to
inform vaccination policy and planning efforts.